Clinical Trials Directory

Trials / Completed

CompletedNCT02005718

Impact of Vitamin D on Endothelial Function and Blood Biomarkers Including CD28 Null Cells in CKD

Impact of Cholecalciferol on Endothelial Fucntion and Blood Biomarkers in Patients With Chronic Kidney Disease

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
36 (actual)
Sponsor
St George's, University of London · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Vitamin D deficiency is common in CKD and assciated with CV complications. Endothelial dysfucntion is common in CKD and is a harbinger of atherosclerosis. The study investigated the impact of Vitamin D on endothelial fucntion and blood biomarkers in CKD.

Conditions

Interventions

TypeNameDescription
DRUGCholecalciferol

Timeline

Start date
2010-06-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2013-12-09
Last updated
2013-12-09

Source: ClinicalTrials.gov record NCT02005718. Inclusion in this directory is not an endorsement.